marketcaparena
Search

    RMTI

    ROCKWELL MEDICAL, INC.

    Company overview

    Market capitalization
    $34.78M
    Employees
    157
    Latest publication
    2026-09-29
    About ROCKWELL MEDICAL, INC.

    Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue17,780,000USD17,336,000USD18,346,000USD15,927,000USD16,071,000USD18,914,000USD24,665,000USD28,316,000USD
    Cost Of Revenue14,537,000USD14,439,000USD14,468,000USD13,655,000USD13,568,000USD15,872,000USD21,034,000USD22,077,000USD
    Gross Profit3,243,000USD2,897,000USD3,878,000USD2,272,000USD2,503,000USD3,042,000USD3,631,000USD6,239,000USD
    Research Development40,000USD—0USD0USD0USD0USD1,000USD0USD
    Selling General Administrative3,687,000USD3,810,000USD3,736,000USD3,325,000USD3,280,000USD3,691,000USD3,306,000USD3,577,000USD
    Selling And Marketing Expenses577,000USD567,000USD540,000USD531,000USD572,000USD711,000USD843,000USD726,000USD
    General And Administrative Expenses3,687,000USD———————
    Total Operating Expenses4,304,000USD4,377,000USD4,276,000USD3,856,000USD3,852,000USD4,402,000USD4,150,000USD4,303,000USD
    Operating Income-1,061,000USD-1,480,000USD-398,000USD-1,584,000USD-1,349,000USD-1,360,000USD-519,000USD1,936,000USD
    Total Other Income Expense Net-111,000USD-125,000USD-156,000USD-169,000USD-143,000USD-155,000USD-237,000USD-272,000USD
    Interest Expense281,000USD282,000USD286,000USD285,000USD276,000USD277,000USD289,000USD302,000USD
    Net Income-1,172,000USD-1,605,000USD-554,000USD-1,753,000USD-1,492,000USD-1,515,000USD-756,000USD1,664,000USD
    Net Income Applicable To Common Shares-1,327,000USD———————
    Interest Income—37,000USD44,000USD55,000USD69,000USD66,000USD29,000USD30,000USD
    Net Interest Income—-245,000USD-242,000USD-230,000USD-207,000USD-211,000USD-260,000USD-272,000USD
    Income Before Tax—-1,605,000USD-554,000USD-1,753,000USD-1,492,000USD-1,515,000USD-756,000USD1,664,000USD
    Net Income From Continuing Ops—-1,605,000USD-554,000USD-1,753,000USD-1,492,000USD-1,515,000USD-756,000USD1,664,000USD
    Ebit—-1,323,000USD-268,000USD-1,468,000USD-1,216,000USD-1,238,000USD-467,000USD1,966,000USD
    Ebitda—-812,000USD278,000USD-1,407,000USD-653,000USD-699,000USD76,000USD2,509,000USD
    Depreciation And Amortization—511,000USD546,000USD61,000USD563,000USD539,000USD543,000USD543,000USD
    Reconciled Depreciation—511,000USD546,000USD544,000USD563,000USD539,000USD543,000USD543,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue69,258,000USD101,489,000USD83,612,000USD72,810,000USD61,931,000USD62,197,000USD61,302,801USD63,388,617USD
    Cost Of Revenue57,563,000USD84,005,000USD74,908,000USD68,733,000USD64,351,000USD59,472,000USD58,463,859USD64,973,157USD
    Gross Profit11,695,000USD17,484,000USD8,704,000USD4,077,000USD-2,420,000USD2,725,000USD2,838,942USD-1,584,540USD
    Research Development0USD19,000USD1,107,000USD3,119,000USD6,835,000USD7,092,000USD6,886,251USD6,742,317USD
    Selling General Administrative14,032,000,000USD14,108,000USD12,142,000USD15,644,000USD15,348,000USD16,182,000USD20,997,948USD22,077,720USD
    Unclassified Operating Expenses-14,015,614,000USD———————
    Total Operating Expenses16,386,000USD16,876,000USD15,374,000USD20,857,000USD27,916,000USD31,145,000USD36,934,232USD29,824,621USD
    Operating Income-4,691,000USD608,000USD-6,670,000USD-16,780,000USD-30,336,000USD-28,420,000USD-34,095,290USD-32,439,161USD
    Interest Income234,000USD92,000USD211,000USD33,000USD22,000USD238,000USD367,077USD535,328USD
    Interest Expense1,124,000USD1,254,000USD2,301,000USD1,936,000USD2,360,000USD1,879,000USD0USD0USD
    Net Interest Income-890,000USD-1,162,000USD-1,420,000USD-1,903,000USD-2,338,000USD-1,641,000USD367,077USD535,328USD
    Income Before Tax-5,314,000USD-480,000USD-8,439,000USD-18,679,000USD-32,674,000USD-30,890,000USD-37,177,972USD-32,125,858USD
    Net Income-5,314,000USD-480,000USD-8,439,000USD-18,679,000USD-32,674,000USD-30,890,000USD-34,128,031USD-32,125,858USD
    Net Income From Continuing Ops-5,314,000USD-480,000USD-9,289,000USD-18,679,000USD-32,674,000USD-30,890,000USD-34,128,031USD-32,125,858USD
    Ebit-4,691,000USD774,000USD-6,138,000USD-16,743,000USD-30,314,000USD-29,011,000USD-34,128,033USD-32,125,853USD
    Ebitda-2,499,000USD2,954,000USD-4,694,000USD-16,167,000USD-27,799,000USD-26,722,000USD-31,475,320USD-31,475,711USD
    Depreciation And Amortization2,192,000USD2,180,000USD1,444,000USD576,000USD2,515,000USD2,289,000USD2,652,713USD650,142USD
    Reconciled Depreciation2,192,000USD2,180,000USD3,061,000USD2,589,000USD2,515,000USD2,289,000USD2,652,713USD650,142USD
    Total Other Income Expense Net-623,000USD-1,088,000USD-1,769,000USD-1,899,000USD-2,338,000USD-2,470,000USD-3,082,682USD-716,697USD
    Selling And Marketing Expenses—2,749,000USD2,125,000USD2,094,000USD5,733,000USD7,871,000USD9,050,033USD1,004,584USD
    Income Tax Expense——1,276,105USD1,899,000USD2,360,000USD1,042,000USD-3,049,972USD313,303USD
    Net Income Applicable To Common Shares———-18,679,000USD-32,674,000USD-30,890,000USD-34,128,031USD-32,125,858USD
    Non Operating Income Net Other—————-2,470,000USD397,259USD313,303USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets56,526,000USD57,423,000USD57,145,000USD57,486,000USD52,625,000USD53,961,000USD59,208,000USD57,084,000USD
    Cash And Equivalents10,519,000USD———————
    Total Current Assets36,360,000USD36,943,000USD38,163,000USD37,514,000USD31,609,000USD33,034,000USD37,030,000USD34,217,000USD
    Other Current Assets441,000USD1,173,000USD1,599,000USD1,515,000USD943,000USD988,000USD1,359,000USD1,171,000USD
    Other Non Current Assets556,000USD———————
    Total Liabilities21,441,000USD———————
    Total Current Liabilities11,174,000USD9,868,000USD9,580,000USD9,582,000USD10,946,000USD11,205,000USD14,091,000USD14,178,000USD
    Other Current Liabilities3,973,000USD———————
    Total Stockholder Equity35,085,000USD35,857,000USD36,981,000USD37,020,000USD30,409,000USD31,522,000USD32,586,000USD29,135,000USD
    Total Equity Including Noncontrolling Interest35,085,000USD———————
    Short Long Term Debt1,768,000USD773,000USD264,000USD462,000USD660,000USD67,000USD268,000USD469,000USD
    Long Term Debt7,235,000USD8,207,000USD8,826,000USD8,737,000USD8,648,000USD8,559,000USD8,472,000USD8,383,000USD
    Net Receivables8,305,000USD8,825,000USD8,143,000USD8,328,000USD8,084,000USD9,670,000USD8,291,000USD8,886,000USD
    Inventory2,817,000USD3,055,000USD3,424,000USD3,964,000USD4,160,000USD5,045,000USD5,778,000USD5,888,000USD
    Property Plant Equipment Net8,862,000USD9,485,000USD7,849,000USD8,696,000USD9,603,000USD9,416,000USD10,344,000USD10,875,000USD
    Goodwill920,000USD———————
    Intangible Assets9,380,000USD9,518,000USD9,656,000USD9,794,000USD9,931,000USD10,069,000USD10,207,000USD10,345,000USD
    Accounts Payable3,179,000USD3,446,000USD1,999,000USD1,523,000USD1,502,000USD1,925,000USD2,869,000USD2,607,000USD
    Short Term Debt1,456,000USD2,692,000USD1,888,000USD2,241,000USD2,737,000USD2,134,000USD2,433,000USD2,610,000USD
    Retained Earnings-405,769,000USD-404,597,000USD-402,992,000USD-402,438,000USD-400,685,000USD-399,193,000USD-397,678,000USD-396,922,000USD
    Accumulated Other Comprehensive Income130,000USD133,000USD131,000USD73,000USD57,000USD60,000USD54,000USD8,000USD
    Total Liab—21,566,000USD20,164,000USD20,466,000USD22,216,000USD22,439,000USD26,622,000USD27,949,000USD
    Other Current Liab—3,660,000USD5,337,000USD5,615,000USD6,596,000USD7,014,000USD8,646,000USD8,564,000USD
    Common Stock—4,000USD4,000USD4,000USD3,000USD3,000USD3,000USD3,000USD
    Capital Stock—4,000USD4,000USD4,000USD3,000USD3,000USD3,000USD3,000USD
    Good Will—921,000USD921,000USD921,000USD921,000USD921,000USD921,000USD921,000USD
    Cash—9,609,000USD10,711,000USD13,610,000USD12,482,000USD11,391,000USD15,662,000USD12,338,000USD
    Cash And Short Term Investments—23,890,000USD24,997,000USD23,707,000USD18,422,000USD17,331,000USD21,602,000USD18,272,000USD
    Current Deferred Revenue—70,000USD356,000USD203,000USD111,000USD132,000USD143,000USD397,000USD
    Net Debt—4,781,000USD1,761,000USD-485,000USD1,525,000USD1,477,000USD-2,127,000USD1,838,000USD
    Short Long Term Debt Total—14,390,000USD12,472,000USD13,125,000USD14,007,000USD12,868,000USD13,535,000USD14,176,000USD
    Short Term Investments—14,281,000USD14,286,000USD10,097,000USD5,940,000USD5,940,000USD5,940,000USD5,934,000USD
    Property Plant Equipment Gross—19,219,000USD18,570,000USD20,237,000USD20,738,000USD20,134,000USD20,746,000USD20,872,000USD
    Common Stock Shares Outstanding—39,418,302shares39,405,302shares36,024,940shares34,311,306shares34,107,640shares32,878,110shares32,420,168shares
    Non Current Assets Total—20,480,000USD18,982,000USD19,972,000USD21,016,000USD20,927,000USD22,178,000USD22,867,000USD
    Non Current Liabilities Total—11,697,999USD10,584,000USD10,884,000USD11,270,000USD11,234,000USD12,531,000USD13,771,000USD
    Non Currrent Assets Other—556,000USD556,000USD561,000USD561,000USD521,000USD706,000USD726,000USD
    Net Working Capital—27,075,000USD28,583,000USD27,932,000USD20,663,000USD21,829,000USD22,939,000USD20,039,000USD
    Unclassified Non Current Liabilities—3,490,999USD1,758,000USD2,147,000USD2,622,000USD2,675,000USD4,059,000USD5,374,000USD
    Unclassified Equity—440,313,000USD439,834,000USD439,377,000USD431,031,000USD430,649,000USD430,204,000USD426,043,000USD
    Non Current Liabilities Other———————14,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets57,145,000USD59,208,000USD52,173,000USD46,635,000USD48,574,000USD77,748,000USD44,317,000USD52,557,784USD
    Intangible Assets9,656,000USD10,207,000USD10,759,000USD———3,320USD3,680USD
    Other Current Assets1,599,000USD1,359,000USD1,063,000USD1,745,000USD2,861,000USD2,706,000USD2,979,000USD1,903,682USD
    Total Liab20,164,000USD26,622,000USD30,882,000USD32,529,000USD46,039,000USD43,578,000USD23,997,000USD25,280,910USD
    Total Stockholder Equity36,981,000USD32,586,000USD21,291,000USD14,106,000USD2,535,000USD34,170,000USD20,320,000USD27,276,874USD
    Other Current Liab5,337,000USD8,646,000USD9,649,000USD7,702,000USD5,090,000USD5,144,000USD4,811,000USD6,396,429USD
    Common Stock4,000USD3,000USD3,000USD1,000USD1,000USD9,000USD7,000USD5,703USD
    Capital Stock4,000USD3,000USD3,000USD1,000USD9,000USD9,000USD6,538USD299,601,960USD
    Retained Earnings-402,992,000USD-397,678,000USD-397,198,000USD-388,759,000USD-370,080,000USD-337,406,000USD-306,516,000USD-272,388,234USD
    Good Will921,000USD921,000USD921,000USD921,000USD921,000USD921,000USD921,000USD920,745USD
    Cash10,711,000USD15,662,000USD8,983,000USD10,102,000USD13,280,000USD48,682,000USD11,795,000USD22,713,980USD
    Cash And Short Term Investments24,997,000USD21,602,000USD10,935,000USD21,492,000USD22,438,000USD58,679,000USD26,045,000USD33,532,039USD
    Total Current Assets38,163,000USD37,030,000USD28,770,000USD35,310,000USD35,288,000USD69,469,000USD36,874,000USD46,825,230USD
    Total Current Liabilities9,580,000USD14,091,000USD16,637,000USD17,691,000USD20,966,000USD12,793,000USD12,374,000USD13,204,511USD
    Current Deferred Revenue356,000USD143,000USD289,000USD1,797,000USD2,315,000USD2,327,000USD2,289,000USD2,316,011USD
    Net Debt1,761,000USD-2,127,000USD4,456,000USD6,261,000USD15,615,000USD-24,745,000USD-7,758,000USD-22,713,980USD
    Short Term Debt1,888,000USD2,433,000USD2,183,000USD4,139,000USD9,822,000USD1,167,000USD2,256,000USD5,546,429USD
    Short Long Term Debt264,000USD268,000USD244,000USD2,134,000USD7,818,000USD—763,422USD—
    Short Long Term Debt Total12,472,000USD13,535,000USD13,439,000USD16,363,000USD28,895,000USD23,937,000USD4,037,000USD—
    Long Term Debt8,826,000USD8,472,000USD8,293,000USD7,555,000USD13,186,000USD20,949,000USD——
    Short Term Investments14,286,000USD5,940,000USD1,952,000USD11,390,000USD9,158,000USD9,997,000USD14,250,000USD10,818,059USD
    Net Receivables8,143,000USD8,291,000USD10,901,000USD6,259,000USD5,913,000USD4,171,000USD4,203,000USD7,350,731USD
    Inventory3,424,000USD5,778,000USD5,871,000USD5,814,000USD4,076,000USD3,913,000USD3,647,000USD4,038,778USD
    Accounts Payable1,999,000USD2,869,000USD4,516,000USD4,053,000USD3,739,000USD4,155,000USD3,018,000USD4,492,071USD
    Property Plant Equipment Net7,849,000USD10,344,000USD11,018,000USD8,605,000USD10,223,000USD5,553,000USD5,646,000USD2,638,293USD
    Property Plant Equipment Gross18,570,000USD20,746,000USD19,822,000USD16,241,000USD17,326,000USD2,642,000USD5,645,935USD2,638,293USD
    Accumulated Other Comprehensive Income131,000USD54,000USD-1,000USD163,000USD52,000USD57,000USD52,000USD63,148USD
    Common Stock Shares Outstanding35,974,000shares31,058,539shares23,322,915shares9,866,844shares8,526,186shares6,874,697shares5,538,049shares4,802,225shares
    Non Current Assets Total18,982,000USD22,178,000USD23,403,000USD11,325,000USD13,286,000USD8,279,000USD7,443,000USD5,732,554USD
    Non Current Liabilities Total10,584,000USD12,531,000USD14,245,000USD14,838,000USD25,073,000USD30,785,000USD11,623,000USD12,076,399USD
    Non Currrent Assets Other556,000USD706,000USD705,000USD1,799,000USD2,142,000USD1,805,000USD876,000USD2,173,516USD
    Net Working Capital28,583,000USD22,939,000USD12,133,000USD17,619,000USD14,322,000USD56,676,000USD24,500,276USD33,620,719USD
    Unclassified Non Current Liabilities1,758,000USD4,059,000USD5,938,000USD4,655,000USD5,873,000USD—-9,843,150USD—
    Unclassified Equity439,834,000USD430,204,000USD418,484,000USD402,700,000USD372,553,000USD371,501,000USD326,770,462USD—
    Non Current Liabilities Other——14,000USD14,000USD14,000USD1,821,000USD11,623,388USD—
    Other Liab———2,614,000USD6,000,000USD8,015,000USD9,842,762USD12,076,399USD
    Other Assets———13,818,000USD2,142,000USD4,716,000USD875,935USD2,173,516USD
    Net Tangible Assets———13,185,000USD1,614,000USD33,249,000USD19,398,758USD26,356,129USD
    Unclassified Non Current Assets———-13,818,000USD-2,142,000USD-4,716,000USD—-2,177,196USD
    Unclassified Current Liabilities———-2,134,000USD-7,818,000USD——-5,546,429USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation1,003,000USD
    Stock Based Compensation882,000USD
    Change To Account Receivables288,000USD
    Change To Inventory607,000USD
    Change To Liabilities816,000USD
    Change In Working Capital2,869,000USD
    Operating Cash Flow1,913,000USD
    Capital Expenditures-1,042,000USD
    Net Investments258,000USD
    Unclassified Investing Cash Flow175,000USD
    Investing Cash Flow-609,000USD
    Net Debt Issuance-232,000USD
    Unclassified Financing Cash Flow-1,264,000USD
    Financing Cash Flow-1,496,000USD
    Change In Cash-192,000USD
    End Cash Flow10,519,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-1,605,000USD-554,000USD-1,753,000USD-1,492,000USD-1,515,000USD-756,000USD1,664,000USD343,000USD
    Depreciation511,000USD546,000USD544,000USD563,000USD539,000USD543,000USD543,000USD549,000USD
    Stock Based Compensation479,000USD457,000USD532,000USD382,000USD445,000USD382,000USD321,000USD338,000USD
    Other Non Cash Items1,137,000USD868,000USD467,000USD600,000USD782,000USD691,000USD907,000USD401,000USD
    Change To Account Receivables-682,000USD-61,000USD-244,000USD1,586,000USD-1,379,000USD586,000USD1,963,000USD254,000USD
    Change To Inventory369,000USD904,000USD257,000USD885,000USD733,000USD-1,000USD-319,000USD190,000USD
    Change In Working Capital-210,000USD1,431,000USD-1,097,000USD1,791,000USD-3,738,000USD5,000USD840,000USD-189,000USD
    Total Cash From Operating Activities-167,000USD2,291,000USD-1,307,000USD1,844,000USD-3,487,000USD865,000USD4,275,000USD1,442,000USD
    Capital Expenditures-425,000USD-86,000USD-229,000USD-164,000USD-63,000USD-395,000USD-191,000USD-286,000USD
    Free Cash Flow-592,000USD2,205,000USD-1,536,000USD1,680,000USD-3,550,000USD470,000USD4,084,000USD1,156,000USD
    Investments128,000USD-4,045,000USD-4,309,000USD-103,000USD-1,000USD-332,000USD-6,112,000USD1,717,000USD
    Total Cashflows From Investing Activities-122,000USD-4,131,000USD-4,309,000USD-103,000USD-1,000USD-332,000USD-6,112,000USD1,717,000USD
    Net Borrowings-313,000USD-309,000USD-322,000USD-215,000USD-347,000USD-343,000USD-341,000USD—
    Total Cash From Financing Activities-813,000USD-1,059,000USD6,744,000USD-650,000USD-783,000USD2,792,000USD2,313,000USD2,065,000USD
    Change In Cash-1,102,000USD-2,899,000USD1,128,000USD1,091,000USD-4,271,000USD3,324,000USD475,000USD5,221,000USD
    Begin Period Cash Flow10,711,000USD13,610,000USD12,482,000USD11,391,000USD15,662,000USD12,338,000USD11,863,000USD6,642,000USD
    End Period Cash Flow9,609,000USD10,711,000USD13,610,000USD12,482,000USD11,391,000USD15,662,000USD12,338,000USD11,863,000USD
    Other Cashflows From Financing Activities-500,000USD-750,000USD-750,000USD-435,000USD-436,000USD-653,000USD-976,000USD1,717,000USD
    Issuance Of Capital Stock—0USD7,816,000USD0USD0USD3,788,000USD3,630,000USD2,203,000USD
    Other Cashflows From Investing Activities——-345,000USD-98,000USD51,000USD—63,000USD—
    Unclassified Financing Cash Flow———————-1,855,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-5,314,000USD-480,000USD-8,439,000USD-18,679,000USD-32,674,000USD-30,890,000USD-34,128,031USD-32,125,858USD
    Depreciation2,192,000USD2,180,000USD1,444,000USD576,000USD2,515,000USD2,289,000USD2,652,713USD650,142USD
    Stock Based Compensation1,816,000USD1,292,000USD932,000USD315,000USD943,000USD475,000USD4,951,777USD4,387,554USD
    Other Non Cash Items2,260,000USD2,737,000USD3,895,000USD2,985,000USD369,000USD294,000USD1,244,606USD1,100,000USD
    Change To Account Receivables-98,000USD2,610,000USD-4,642,000USD-346,000USD-1,742,000USD32,000USD2,776,789USD-623,948USD
    Change To Inventory2,779,000USD-332,000USD1,176,000USD-2,101,000USD-656,000USD-1,306,000USD316,872USD-835,641USD
    Change In Working Capital-1,613,000USD-1,527,000USD-7,244,000USD-2,126,000USD-4,843,000USD-2,958,000USD-1,975,613USD-3,432,100USD
    Total Cash From Operating Activities-659,000USD4,202,000USD-9,412,000USD-16,929,000USD-33,534,000USD-29,641,000USD-27,254,548USD-20,419,934USD
    Capital Expenditures-542,000USD-1,011,000USD-284,000USD-281,000USD-522,000USD-1,046,000USD-1,337,452USD-994,256USD
    Free Cash Flow-1,201,000USD3,191,000USD-9,696,000USD-17,210,000USD-34,056,000USD-30,687,000USD-28,592,000USD-21,414,190USD
    Investments-8,002,000USD-4,866,000USD-1,835,000USD-2,396,000USD311,000USD4,258,000USD38,265,664USD33,895,481USD
    Total Cashflows From Investing Activities-8,544,000USD-4,866,000USD-3,045,000USD-2,396,000USD311,000USD3,212,000USD-4,749,782USD12,723,498USD
    Net Borrowings-1,193,000USD-1,204,000USD-3,514,000USD-13,193,000USD-2,280,000USD21,737,000USD-1,145,132USD-1,145,132USD
    Total Cash From Financing Activities4,252,000USD7,348,000USD11,342,000USD16,150,000USD-2,179,000USD63,316,000USD21,084,876USD22,003,499USD
    Issuance Of Capital Stock7,816,000USD10,181,000USD13,763,000USD30,016,000USD107,000USD45,473,000USD24,160,721USD22,000,000USD
    Change In Cash-4,951,000USD6,679,000USD-1,119,000USD-3,178,000USD-35,402,000USD36,887,000USD-10,919,454USD14,307,063USD
    Begin Period Cash Flow15,662,000USD8,983,000USD10,102,000USD13,280,000USD48,682,000USD11,795,000USD22,713,980USD8,406,917USD
    End Period Cash Flow10,711,000USD15,662,000USD8,983,000USD10,102,000USD13,280,000USD48,682,000USD11,794,526USD22,713,980USD
    Other Cashflows From Investing Activities190,000USD-1,011,000USD—-2,115,000USD833,000USD4,258,000USD-42,427,994USD250,400USD
    Other Cashflows From Financing Activities-2,371,000USD-1,629,000USD-5,000USD14,809,000USD311,000USD41,125,000USD-1,503,466USD3,499USD
    Unclassified Investing Cash Flow—2,022,000USD—2,396,000USD—-4,258,000USD—-20,428,127USD
    Unclassified Financing Cash Flow——1,098,000USD14,534,000USD—22,973,000USD24,160,721USD1,141,633USD
    Change To Liabilities———-3,512,000USD-2,449,000USD-751,000USD-3,726,513USD-2,124,139USD
    Sale Purchase Of Stock———0USD-6,000USD-19,000USD-279,347USD22,003,499USD
    Dividends Paid————-6,000USD-22,500,000USD-147,900USD—
    Cash And Cash Equivalents Changes—————36,887,000USD-10,964,906USD14,307,063USD
    Unclassified Operating Cash Flow—————1,149,000USD—9,000,328USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyInternational2,773,000USD0001628280-26-031663
    Q1 2026Quarterly · 2026-03-31GeographyUnited States14,563,000USD0001628280-26-031663
    Q4 2025Quarterly · 2025-12-31GeographyInternational2,437,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States15,909,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational8,900,000USD0001628280-26-021186
    FY 2025Yearly · 2025-12-31GeographyUnited States60,358,000USD0001628280-26-021186
    Q3 2025Quarterly · 2025-09-30GeographyInternational2,103,000USD0001628280-25-051290
    Q3 2025Quarterly · 2025-09-30GeographyUnited States13,824,000USD0001628280-25-051290
    Q3 2025Quarterly · 2025-09-30ProductConcentrate Products15,927,000USD0001628280-25-051290
    Q3 2025Quarterly · 2025-09-30ProductDrug Revenue0USD0001628280-25-051290
    Q2 2025Quarterly · 2025-06-30GeographyInternational1,882,000USD0001041024-25-000011
    Q2 2025Quarterly · 2025-06-30GeographyUnited States14,189,000USD0001041024-25-000011
    Q2 2025Quarterly · 2025-06-30ProductConcentrate Products16,071,000USD0001041024-25-000011
    Q2 2025Quarterly · 2025-06-30ProductDrug Revenue0USD0001041024-25-000011
    Q1 2025Quarterly · 2025-03-31GeographyInternational2,478,000USD0001628280-26-031663
    Q1 2025Quarterly · 2025-03-31GeographyUnited States16,436,000USD0001628280-26-031663
    Q1 2025Quarterly · 2025-03-31ProductConcentrate Product License Fee325,000USD0001628280-26-031663
    Q1 2025Quarterly · 2025-03-31ProductConcentrate Products18,589,000USD0001628280-26-031663
    Q4 2024Quarterly · 2024-12-31GeographyInternational2,797,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States21,868,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational9,231,000USD0001628280-26-021186
    FY 2024Yearly · 2024-12-31GeographyUnited States92,258,000USD0001628280-26-021186
    Q4 2024Quarterly · 2024-12-31ProductConcentrate Products24,653,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDrug Revenue12,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductConcentrate Products101,443,000USD0001628280-26-021186
    FY 2024Yearly · 2024-12-31ProductLicense Fees Revenue46,000USD0001628280-26-021186
    Q3 2024Quarterly · 2024-09-30GeographyInternational2,069,000USD0001628280-25-051290
    Q3 2024Quarterly · 2024-09-30GeographyUnited States26,247,000USD0001628280-25-051290
    Q3 2024Quarterly · 2024-09-30ProductConcentrate Products28,305,000USD0001628280-25-051290
    Q3 2024Quarterly · 2024-09-30ProductDrug Revenue11,000USD0001628280-25-051290
    Q2 2024Quarterly · 2024-06-30GeographyInternational2,623,000USD0001041024-25-000011
    Q2 2024Quarterly · 2024-06-30GeographyUnited States23,209,000USD0001041024-25-000011
    Q2 2024Quarterly · 2024-06-30ProductConcentrate Products25,820,000USD0001041024-25-000011
    Q2 2024Quarterly · 2024-06-30ProductDrug Revenue12,000USD0001041024-25-000011
    Q1 2024Quarterly · 2024-03-31ProductConcentrate Products22,665,000USD0001628280-25-024434
    Q1 2024Quarterly · 2024-03-31ProductDrug Revenue11,000USD0001628280-25-024434
    FY 2023Yearly · 2023-12-31GeographyInternational9,269,000USD0001628280-25-013983
    FY 2023Yearly · 2023-12-31GeographyUnited States74,343,000USD0001628280-25-013983
    Q4 2023Quarterly · 2023-12-31ProductConcentrate Products22,082,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductDrug Revenue11,000USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductConcentrate Product License Fee1,472,000USD0001628280-24-012572
    FY 2023Yearly · 2023-12-31ProductConcentrate Product Sales79,802,000USD0001628280-24-012572
    FY 2023Yearly · 2023-12-31ProductDrug Product Sales0USD0001628280-24-012572
    FY 2023Yearly · 2023-12-31ProductOther2,338,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31GeographyInternational7,045,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31GeographyUnited States65,765,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31ProductConcentrate Product License Fee2,489,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31ProductConcentrate Product Sales69,162,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31ProductDrug License Fee256,000USD0001628280-24-012572
    FY 2022Yearly · 2022-12-31ProductDrug Product Sales903,000USD0001628280-24-012572
    FY 2021Yearly · 2021-12-31GeographyInternational6,540,000USD0001628280-23-009774
    FY 2021Yearly · 2021-12-31GeographyUnited States55,391,000USD0001628280-23-009774
    FY 2020Yearly · 2020-12-31GeographyInternational5,619,000USD0001628280-22-008830
    FY 2020Yearly · 2020-12-31GeographyUnited States56,578,000USD0001628280-22-008830
    FY 2019Yearly · 2019-12-31GeographyInternational6,511,000USD0001628280-21-006280
    FY 2019Yearly · 2019-12-31GeographyUnited States54,792,000USD0001628280-21-006280
    FY 2018Yearly · 2018-12-31GeographyInternational9,004,000USD0001628280-20-003683
    FY 2018Yearly · 2018-12-31GeographyUnited States54,385,000USD0001628280-20-003683
    FY 2018Yearly · 2018-12-31ProductConcentrate Products63,116,000USD0001558370-19-002200
    FY 2018Yearly · 2018-12-31ProductDrug Revenue273,000USD0001558370-19-002200
    FY 2017Yearly · 2017-12-31ProductConcentrate Products57,071,000USD0001558370-19-002200
    FY 2017Yearly · 2017-12-31ProductDrug Revenue229,000USD0001558370-19-002200

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.